PATENT CLAIM ANALYSIS

Application Number: 15992039
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["514", "006700"]

Abstract:
The invention provides peptides and analogs of INGAP and HIP peptides. The peptides and analogs can be used in methods for treating various diseases and conditions. Such diseases and conditions can include impaired pancreatic function, treating a metabolic disease, for example, diabetes, both type 1 and type 2 diabetes, islets induction, expansion and proliferation for transplantation, promoting neuroprotection or nerve regeneration, promoting liver regeneration or inhibiting inflammation.

Claim (Index 32):
A method for promoting neuroprotection or nerve regeneration, comprising contacting a nerve cell with the peptide or analog of  claim 1 .

Metadata:
- Claim Count in Document: 4.0
- Percentile: 93.0
- Lexical Diversity: 1.625
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14417110', '15177206', '12635053', '12121123', '13168461']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7703933154821057
- 35 USC 102 Novelty (BERT): 0.5644332490563926
- Combined Prediction Score: 0.7497973088395344
- Mean Citation Score: 407.264282
- Max Citation Score: 539.7091
- Similarity Product: 293.42943611657023

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test